Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian population.

Urologia - 1 May 2024

Malakar Subhajit, Chatterjee Srilagna, Das Madhusudhan, Pal Dilip Kumar

Abstract excerpt

INTRODUCTION: Renal Cell Carcinoma (RCC), which accounts for 2%-3% of all adult malignant neoplasms with a male-to-female predominance of 1.9 to 1 with typical presentation between 55 and 75 years. The phosphoinositide-3-kinase-protein kinase B/Akt (PI3KPKB/Akt) pathway is a main pathway in control of cell growth. mTOR pathway plays a key role in the pathogenesis of RCC. MATERIAL AND METHODS: Its a prospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Renal Cell
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Proto-Oncogene Proteins c-akt

Share to TOR Serine-Threonine Kinases

Source

Identifiers

PMID: 38205940
DOI: 10.1177/03915603231222081

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian population.PMID 38205940Read ↗

Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.Semantic proximity Read ↗

A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk.Semantic proximity Read ↗

Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.Semantic proximity Read ↗

Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis.Semantic proximity Read ↗

Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancerSemantic proximity Read ↗

Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population.Semantic proximity Read ↗

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinomaSemantic proximity Read ↗

Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.Semantic proximity Read ↗

The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy.Semantic proximity Read ↗

Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines.Semantic proximity Read ↗

Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.Semantic proximity Read ↗

Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.